{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:28:22Z","timestamp":1785544102252,"version":"3.56.0"},"reference-count":173,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.amjopharm.2006.06.006","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T18:53:07Z","timestamp":1153507987000},"page":"168-192","source":"Crossref","is-referenced-by-count":84,"title":["Management of chronic insomnia in elderly persons"],"prefix":"10.1016","volume":"4","author":[{"given":"Kevin T.","family":"Bain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2006.06.006_bib1","first-page":"75","article-title":"Review of insomnia: The sleep cycle and treatment options","volume":"69","author":"Mathews","year":"2003","journal-title":"Pharm Times"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(04)17480-1","article-title":"Insomnia","volume":"364","author":"Sateia","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/sleep\/23.2.1l","article-title":"Evaluation of chronic insomnia. An American Academy of Sleep Medicine review","volume":"23","author":"Sateia","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib4","series-title":"Summary of findings. 2005 Sleep in America Poll","author":"National Sleep Foundation","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1532-5415.1998.tb02533.x","article-title":"Sleep complaints in community-dwelling older persons: Prevalence, associated factors, and reported causes","volume":"46","author":"Maggi","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib6","first-page":"S1","article-title":"Pharmacists' role in recognizing and managing patients with insomnia","volume":"70","author":"Simonson","year":"2004","journal-title":"Pharm Times"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpsychores.2004.02.010","article-title":"Sleep disturbances and chronic disease in older adults: Results of the 2003 National Sleep Foundation Sleep in America Survey","volume":"56","author":"Foley","year":"2004","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/sleep\/18.6.425","article-title":"Sleep complaints among elderly persons: An epidemiologic study of three communities","volume":"18","author":"Foley","year":"1995","journal-title":"Sleep"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2006.06.006_bib9","first-page":"S366","article-title":"Incidence and remission of insomnia among elderly adults: An epidemiologic study of 6,800 persons over three years","volume":"22","author":"Foley","year":"1999","journal-title":"Sleep"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2006.06.006_bib10","first-page":"S379","article-title":"Quality of life in people with insomnia","volume":"22","author":"Zammit","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2165\/00019053-199814060-00004","article-title":"Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees","volume":"14","author":"Hatoum","year":"1998","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib12","series-title":"Applied Therapeutics: The Clinical Use of Drugs","first-page":"1","article-title":"Sleep disorders","author":"Dopheide","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.1989.03430110069030","article-title":"Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?","volume":"262","author":"Ford","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0006-3223(95)00188-3","article-title":"Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults","volume":"39","author":"Breslau","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0163-8343(97)00056-X","article-title":"The morbidity of insomnia uncomplicated by psychiatric disorders","volume":"19","author":"Weissman","year":"1997","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib16","first-page":"289","article-title":"The relationship between chronically disrupted sleep and healthcare use","volume":"25","author":"Kapur","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archfami.9.2.143","article-title":"Self-reported arthritis-related disruptions in sleep and daily life and the use of medical, complementary, and self-care strategies for arthritis: The National Survey of Self-care and Aging","volume":"9","author":"Jordan","year":"2000","journal-title":"Arch Fare Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1176\/ajp.154.10.1417","article-title":"Prevalence, burden, and treatment of insomnia in primary care","volume":"154","author":"Simon","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02599573","article-title":"Sleep problems and their correlates in a working population","volume":"10","author":"Kuppermann","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/sleep\/25.6.621","article-title":"Medical and socio-professional impact of insomnia","volume":"25","author":"Leger","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib21","first-page":"648","article-title":"Sleepiness and sleep disorders in shift workers: A study on a group of Italian police officers","volume":"25","author":"Garbarino","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1532-5415.2000.tb02596.x","article-title":"Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64\u201399 years","volume":"48","author":"Brassington","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib23","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1046\/j.1532-5415.2003.51566.x","article-title":"Selected as the best paper in the 1990s: Reducing frailty and falls in older persons: An investigation of tai chi and computerized balance training","volume":"51","author":"Wolf","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1532-5415.2005.53304.x","article-title":"Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes","volume":"53","author":"Avidan","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 7","key":"10.1016\/j.amjopharm.2006.06.006_bib25","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1111\/j.1532-5415.2005.53392.x","article-title":"Prevalence and comorbidity of insomnia and effect on functioning in elderly populations","volume":"53","author":"Ancofi-Israel","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJM199001253220406","article-title":"Drug therapy: The diagnosis and management of insomnia","volume":"322","author":"Gillin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib27","series-title":"Insomnia: Principles and Management","first-page":"3","article-title":"Diagnosis and classification of insomnia disorders","author":"Buysse","year":"2003"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib28","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib29","series-title":"International Classification of Sleep Disorders: Diagnostic and Coding Manual","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib30","series-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","year":"2004"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/sleep\/25.2.221","article-title":"Diagnostic codes associated with hypnotic medications during outpatient physician-patient encounters in the United States from 1990\u20131998","volume":"25","author":"McCall","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1176\/ajp.154.10.1412","article-title":"Clinical factors contributing to the differential diagnosis of primary insomnia and insomnia related to mental disorders","volume":"154","author":"Nowell","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMcp043762","article-title":"Clinical practice. Chronic insomnia","volume":"353","author":"Silber","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/sleep\/17.7.630","article-title":"Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM IV and ICD-10 categories: A report from the APA\/ NIMH DSM-IV field trial","volume":"17","author":"Buysse","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib35","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/ajp.151.9.1351","article-title":"Diagnostic concordance for DSM-IV sleep disorders: A report from the APA\/NIMH DSM-IV field trial","volume":"151","author":"Buysse","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0022-3956(97)00002-2","article-title":"Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders","volume":"31","author":"Ohayon","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib37","first-page":"HS23","article-title":"Pharmacotherapy in managing insomnia: Assessing patient needs and outcomes","volume":"2","author":"Chavez","year":"2005","journal-title":"US Pharm"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib38","first-page":"102","article-title":"Newer options in the management of insomnia","volume":"30","author":"Dopheide","year":"2005","journal-title":"US Pharm"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib39","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjopharm.2006.06.006_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/s1389-9457(02)00242-3","article-title":"A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials","volume":"4","author":"McCall","year":"2003","journal-title":"Sleep Med"},{"issue":"Suppl 7","key":"10.1016\/j.amjopharm.2006.06.006_bib41","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1111\/j.1532-5415.2005.53393.x","article-title":"Diagnosis and management of insomnia in older people","volume":"53","author":"McCall","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/smrv.2002.0266","article-title":"Cognitive behaviour therapy for primary insomnia: Can we rest yet?","volume":"7","author":"Harvey","year":"2003","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/sleep\/22.8.1128","article-title":"Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report","volume":"22","author":"Chesson","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib44","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1176\/ajp.151.8.1172","article-title":"Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy","volume":"151","author":"Morin","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1037\/0022-006X.63.1.79","article-title":"Identifying effective psychological treatments for insomnia: A meta-analysis","volume":"63","author":"Murtagh","year":"1995","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/ajp.148.1.121","article-title":"Efficacy of behavioral versus triazolam treatment in persistent sleeponset insomnia","volume":"148","author":"McClusky","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.ajp.159.1.5","article-title":"Comparative metaanalysis of pharmacotherapy and behavior therapy for persistent insomnia","volume":"159","author":"Smith","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib48","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/archinte.164.17.1888","article-title":"Cognitive behavior therapy and pharmacotherapy for insomnia: A randomized controlled trial and direct comparison","volume":"164","author":"Jacobs","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib49","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.281.11.991","article-title":"Behavioral and pharmacological therapies for late-fife insomnia: A randomized controlled trial","volume":"281","author":"Morin","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib50","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/sleep\/20.12.1111","article-title":"Can we mix behavioral therapy with hypnotics when treating insomniacs?","volume":"20","author":"Hauri","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0005-7967(99)00157-6","article-title":"The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: Implementation and evaluation of a sleep clinic in general medical practice","volume":"39","author":"Espie","year":"2001","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib52","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jama.285.14.1856","article-title":"Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial","volume":"285","author":"Edinger","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib53","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1532-5415.2001.49161.x","article-title":"The role of benzodiazepines in the treatment of insomnia: Meta-analysis of benzodiazepine use in the treatment of insomnia","volume":"49","author":"Holbrook","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/0735-7028.23.2.131","article-title":"Therapeutic issues in the behavioral treatment of insomnia","volume":"23","author":"Chambers","year":"1992","journal-title":"Prof Psychol Res Pract"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1207\/S15402010BSM0104_2","article-title":"Self-efficacy and adherence to cognitive-behavioral treatment of insomnia","volume":"1","author":"Bouchard","year":"2003","journal-title":"Behav Sleep Med"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2006.06.006_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-3999(93)90024-A","article-title":"The nuts and bolts of behavioral therapy for insomnia","volume":"37","author":"Sloan","year":"1993","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib57","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1001\/jama.1997.03550240060035","article-title":"Benzodiazepines and zolpidem for chronic insomnia: A metaanalysis of treatment efficacy","volume":"278","author":"Nowell","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1087-0792(03)00042-X","article-title":"The treatment of chronic insomnia: Drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium","volume":"8","author":"Mendelson","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib59","first-page":"551","article-title":"Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening-temporal stability of subtypes in a longitudinal study on general practice attenders","volume":"17","author":"Hohagen","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/appi.ps.56.3.332","article-title":"Diagnosis and treatment of chronic insomnia: A review","volume":"56","author":"Benca","year":"2005","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib61","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<851::AID-GPS33>3.0.CO;2-L","article-title":"The use of non-prescription sleep products in the elderly","volume":"14","author":"Sproule","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1087-0792(03)00025-X","article-title":"Treatment of insomnia associated with clinical depression","volume":"8","author":"Jindal","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4088\/JCP.v58n0602","article-title":"Sleep disturbances and suicidal behavior in patients with major depression","volume":"58","author":"Agargun","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib64","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.286.22.2823","article-title":"Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey","volume":"286","author":"Zhan","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 17","key":"10.1016\/j.amjopharm.2006.06.006_bib65","first-page":"28","article-title":"Antidepressant treatment of the depressed patient with insomnia","volume":"60","author":"Thase","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-3223(00)00882-9","article-title":"Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: A pilot study","volume":"48","author":"Winokur","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000067812","article-title":"Effects of mirtazapine on sleep polygraphic variables in major depression","volume":"46","author":"Schittecatte","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib68","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.v64n1013","article-title":"Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depres sion and insomnia","volume":"64","author":"Winokur","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.1983.tb04977.x","article-title":"Trazodone enhances sleep in subjective quality but not in objective duration","volume":"16","author":"Montgomery","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib70","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/BF00172629","article-title":"Effects of trazodone on the sleep of depressed subjects-a polygraphic study","volume":"95","author":"Mouret","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib71","first-page":"13","article-title":"Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients","volume":"51","author":"Scharf","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib72","first-page":"18","article-title":"Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults","volume":"51","author":"Ware","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1440-1819.1998.00403.x","article-title":"Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects","volume":"52","author":"Yamadera","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1272\/jnms.69.333","article-title":"Effects of trazodone and imipramine on the biological rhythm: An analysis of sleep EEG and body core temperature","volume":"69","author":"Suzuki","year":"2002","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib75","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF02245272","article-title":"Effects of trazodone on EEG sleep and clinical state in major depression","volume":"107","author":"van Bemmel","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4088\/JCP.v63n0605","article-title":"Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression","volume":"63","author":"Thase","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0006-3223(98)00092-4","article-title":"Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder","volume":"44","author":"Rush","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00432013","article-title":"Trazodone\u2014a comparison of single night-time and divided daily dosage regimens","volume":"84","author":"Brooks","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1440-1819.1999.00532.x","article-title":"Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: Dose-finding study with no concomitant use of hypnotic agent","volume":"53","author":"Mashiko","year":"1999","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib80","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1176\/ajp.151.7.1069","article-title":"Trazodone for antidepressant-associated insomnia","volume":"151","author":"Nierenberg","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib81","first-page":"83","article-title":"Possible trazodone potentiation of fluoxetine: A case series","volume":"53","author":"Nierenberg","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00004714-199706000-00004","article-title":"A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients","volume":"17","author":"Armitage","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib83","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v58n0502","article-title":"A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial","volume":"58","author":"Gillin","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1192\/bjp.180.6.528","article-title":"Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression","volume":"180","author":"Hicks","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0006-3223(92)90101-5","article-title":"Nefazodone\u2014a novel antidepressant-may increase REM sleep","volume":"31","author":"Sharpley","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/npp.1994.14","article-title":"The effects of nefazodone on sleep architecture in depression","volume":"10","author":"Armitage","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib87","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02246410","article-title":"The effects of paroxetine and nefazodone on sleep: A placebo controlled trial","volume":"126","author":"Sharpley","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib88","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2004.05.042","article-title":"Nefazodone in primary insomnia: An open pilot study","volume":"28","author":"Wiegand","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/hup.594","article-title":"Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: A systematic review and meta-analysis","volume":"19","author":"Dundar","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib90","first-page":"38","article-title":"A review of the safety profiles of benzodiazepine hypnotics","author":"Roth","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib91","series-title":"Prosom [package insert]","year":"2004"},{"issue":"Suppl 4","key":"10.1016\/j.amjopharm.2006.06.006_bib92","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1185\/03007998409109545","article-title":"Pharmacokinetics of benzodiazepines: Metabolic pathways and plasma level profiles","volume":"8","author":"Jochemsen","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib93","series-title":"Pharmacotherapy: A Pathophysiologic Approach","first-page":"1208","article-title":"Sleep disorders","author":"Jermain","year":"1999"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib94","series-title":"Dalmane [package insert]","year":"2000"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib95","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/clpt.1984.70","article-title":"Multiple-dose quazepamkinetics","volume":"35","author":"Chung","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/clpt.1984.146","article-title":"Effect of sleep on quazepam kinetics","volume":"36","author":"Hilbert","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib97","series-title":"Restoril [package insert]","year":"2004"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib98","series-title":"Halcion [package insert]","year":"2003"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib99","series-title":"Lunesta [package insert]","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib101","series-title":"Sonata [package insert]","year":"2004"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib102","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1345\/aph.17111","article-title":"Beyond benzodiazepines: Alternative pharmacologic agents for the treatment of insomnia","volume":"32","author":"Wagner","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib103","series-title":"Ambien [package insert]","year":"2004"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00023210-200519010-00008","article-title":"Zolpidem: A review of its use in the management of insomnia","volume":"19","author":"Swainston Harrison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib105","series-title":"Ambien CR [package insert]","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib106","series-title":"Rozerem [package insert]","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib107","first-page":"303","article-title":"Ramelteon (TAK-375), a selective MTI\/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment","volume":"28","author":"Roth","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib108","series-title":"Therapeutics in the Elderly","first-page":"257","article-title":"Drug disposition and response in the elderly","author":"Chapron","year":"2000"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib109","first-page":"1564","article-title":"Principles of drug therapy for the elderly patient","volume":"78","author":"Bressler","year":"2003"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib110","first-page":"225","article-title":"Metaanalysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib111","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(90)90213-W","article-title":"Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: Placing the elderly at risk","volume":"89","author":"Short","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib112","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1532-5415.2000.tb04758.x","article-title":"Long-term continuous use of benzodiazepines by older adults in Quebec: Prevalence, incidence and risk factors","volume":"48","author":"Egan","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib113","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/089198870001300309","article-title":"Defining patterns of benzodiazepine use in older adults","volume":"13","author":"Llorente","year":"2000","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib114","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291703008213","article-title":"Older adults and withdrawal from benzodiazepine hypnotics in general practice: Effects on cognitive function, sleep, mood and quality of life","volume":"33","author":"Curran","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib115","first-page":"731","article-title":"Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients","volume":"68","author":"Rummans","year":"1993"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib116","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib117","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1355617705050332","article-title":"An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use","volume":"11","author":"Barker","year":"2005","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib118","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1532-5415.2003.51502.x","article-title":"Benzodiazepine use and physical performance in communitydwelling older women","volume":"51","author":"Gray","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib119","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: A systematic review and metaanalysis: I. Psychotropic drugs","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib120","first-page":"799","article-title":"Benzodiazepine use and motor vehicle accidents. Systematic review of reported association","volume":"44","author":"Thomas","year":"1998","journal-title":"Can Farn Physician"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpsychires.2003.10.003","article-title":"Chronic benzodiazepine usage and withdrawal in insomnia patients","volume":"38","author":"Poyares","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib122","first-page":"15","article-title":"Relative affinity of quazepam for type-1 benzodiazepine receptors in brain","volume":"52","author":"Wamsley","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib123","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1053\/smrv.2000.0126","article-title":"Non-benzodiazepines for the treatment of insomnia","volume":"4","author":"Wagner","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib124","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.v65n0816","article-title":"Longterm, non-nightly administration of zolpidem in the treatment of patients with primary insomnia","volume":"65","author":"Perlis","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib125","first-page":"192","article-title":"A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia","volume":"55","author":"Scharf","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/030006059302100402","article-title":"Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia","volume":"21","author":"Kummer","year":"1993","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib127","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v60n1005","article-title":"Zolpidem for persistent insomnia in SSRI-treated depressed patients","volume":"60","author":"Asnis","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/030006059101900313","article-title":"Long-term treatment of insomnia with zolpidem: A multicentre general practitioner study of 107 patients","volume":"19","author":"Schlich","year":"1991","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00002018-200528040-00003","article-title":"Benefit-risk assessment of zaleplon in the treatment of insomnia","volume":"28","author":"Barbera","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00044011-199816050-00001","article-title":"Efficacy and tolerability of 14-day administration of zaleplon 5mg and 10mg for the treatment of primary insomnia","volume":"16","author":"Walsh","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib131","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4088\/JCP.v60n0806","article-title":"Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic","volume":"60","author":"Elie","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib132","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004850-200015030-00003","article-title":"Zaleplon improves sleep without producing rebound effects in outpatients with insomnia","volume":"15","author":"Fry","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1389-9457(99)00006-4","article-title":"A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia","volume":"1","author":"Walsh","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib134","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/1099-1166(200008)15:8<704::AID-GPS183>3.0.CO;2-S","article-title":"Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia","volume":"15","author":"Hedner","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/PCC.v01n0404","article-title":"Zaleplon, a novel nonbenzodiazepine hypnotic, effectively treats insomnia in elderly patients without causing rebound effects","volume":"1","author":"Ancoli-Israel","year":"1999","journal-title":"Print Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib136","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002826-200001000-00004","article-title":"Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia","volume":"23","author":"Walsh","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.sleep.2005.06.004","article-title":"An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia","volume":"6","author":"Roth","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib138","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(01)00851-2","article-title":"Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite","volume":"415","author":"Carlson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib139","first-page":"S257","article-title":"Polysomnographic and patient-reported evaluation of the efficacy and safety of eszopiclone in elderly subjects with chronic insomnia","volume":"27","author":"Erman","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/sleep\/28.6.720","article-title":"A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia","volume":"28","author":"Scharf","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib141","series-title":"Insomnia: Indiplon, IR & MR formulations","year":"2006"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib142","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib143","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2004.09.007","article-title":"Neurochemical properties of ramelteon (TAK-375), a selective MT1\/MT2 receptor agonist","volume":"48","author":"Kato","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib144","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0006-8993(90)90214-V","article-title":"Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: Effect of age and Alzheimer's disease","volume":"528","author":"Skene","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6123(08)64570-7","article-title":"Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease","volume":"93","author":"Mirmiran","year":"1992","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib146","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.sleep.2004.07.009","article-title":"Melatonin, sleep, and circadian rhythms: Rationale for development of specific melatonin agonists","volume":"5","author":"Turek","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib147","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/sleep\/20.10.908","article-title":"Sleep-promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanisms?","volume":"20","author":"Sack","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib148","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000123997","article-title":"Bioavailability of oral melatonin in humans","volume":"39","author":"Waldhauser","year":"1984","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib149","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/00912700022009422","article-title":"The absolute bioavailability of oral melatonin","volume":"40","author":"DeMuro","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib150","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM199704033361418","article-title":"Variable bioavailability of oral melatonin","volume":"336","author":"Di","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib151","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/sleep\/20.10.916","article-title":"A critical evaluation of the hypnotic efficacy of melatonin","volume":"20","author":"Mendelson","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib152","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/sleep\/23.5.1i","article-title":"Hypnotic activity of melatonin","volume":"23","author":"Stone","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib153","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/074873049701200620","article-title":"Efficacy of melatonin as a sleep-promoting agent","volume":"12","author":"Zhdanova","year":"1997","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib154","first-page":"899","article-title":"Melatonin: A sleep-promoting hormone","volume":"20","author":"Zhdanova","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib155","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/sleep\/27.7.1319","article-title":"The sleeppromoting action of ramelteon (TAK-375) in freely moving cats","volume":"27","author":"Miyamoto","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2004.08.035","article-title":"Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys","volume":"1027","author":"Yukuhiro","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0748730404269890","article-title":"Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats","volume":"20","author":"Hirai","year":"2005","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib158","first-page":"A298","article-title":"Phase II study of the selective ML-1 receptor agonist TAK-375 in subjects with primary chronic insomnia","volume":"26","author":"Erman","year":"2003","journal-title":"Sleep"},{"issue":"Suppl 4","key":"10.1016\/j.amjopharm.2006.06.006_bib159","first-page":"2","article-title":"Phase III outpatient trial of ramelteon for the treatment of chronic insomnia in elderly patients","volume":"53","author":"Roth","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib160","series-title":"Program and abstracts of the 45th Annual Meeting of the New Clinical Drug Evaluation Unit","article-title":"Phase III study to determine the efficacy of ramelteon in elderly patients with chronic insomnia","author":"Roth","year":"2005"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib161","first-page":"A228 A229","article-title":"Double-blind, placebo-controlled polysomnography and outpatient trial to evaluate the efficacy and safety of ramelteon in adult patients with chronic insomnia","volume":"28","author":"Zammit","year":"2005","journal-title":"Sleep"},{"issue":"Suppl 2","key":"10.1016\/j.amjopharm.2006.06.006_bib162","first-page":"S50","article-title":"Phase III study of ramelteon in a first-night-effect model of transient insomnia","volume":"6","author":"Zammit","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib163","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1532-5415.2005.00571.x","article-title":"Benzodiazepine use and physical disability in community-dwelling older adults","volume":"54","author":"Gray","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib164","first-page":"4","article-title":"Clinical distinctions between longacting and short-acting benzodiazepines","volume":"53","author":"Mendelson","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/gerona\/60.5.622","article-title":"Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study","volume":"60","author":"Landi","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib166","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.1997.03550010041037","article-title":"Benzodiazepine use and risk of motor vehicle crash in the elderly","volume":"278","author":"Hemmelgarn","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib167","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1046\/j.1532-5415.2002.50453.x","article-title":"Central nervous system-active medications and risk for falls in older women","volume":"50","author":"Ensrud","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib168","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bmj.327.7417.712","article-title":"Association between falls in elderly women and chronic diseases and drug use: Cross sectional study","volume":"327","author":"Lawlor","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib169","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0741-8329(02)00223-9","article-title":"Association between use of sedatives or hypnotics, alcohol consumption, or other risk factors and a single injurious fall or multiple injurious falls: A longitudinal general population study","volume":"28","author":"Stenbacka","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib170","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2165\/00002512-200522090-00004","article-title":"Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: A comparative review","volume":"22","author":"Allain","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib171","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1532-5415.2005.53303.x","article-title":"Claims data studies of sedativehypnotics and hip fractures in older people: Exploring residual confounding using survey information","volume":"53","author":"Schneeweiss","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2006.06.006_bib172","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1532-5415.2001.49280.x","article-title":"Zolpidem use and hip fractures in older people","volume":"49","author":"Wang","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 9","key":"10.1016\/j.amjopharm.2006.06.006_bib173","first-page":"31","article-title":"Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds","volume":"66","author":"Griffiths","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594606000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594606000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T06:06:52Z","timestamp":1555740412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594606000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":173,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1543594606000286"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2006.06.006","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}